DIVERSITY AND INCLUSION IN
CAR T-CELL THERAPY CLINICAL TRIALS
As the leader in cell therapy, Kite is dedicated to addressing inequities in clinical research and building
trust within diverse communities.
We recognize the importance of keeping patients at the center of our work and this includes removing any barriers to care that exist. When we build equity in clinical trials for historically underrepresented groups, it paves a pathway for access to the latest advancements in medicine, which improves outcomes and healthcare for all.
Rolondo Enoch
Director, Head of Diversity and Inclusion in Clinical Trials, Kite
OUR FOCUS
ADVANCING CLINICAL TRIAL
DIVERSITY AND INCLUSION
Here at Kite, our goal is to create an environment where patients across all backgrounds are
seen, heard and empowered.
Putting Patients First
By focusing on cultural awareness and humility, we strive to recognize and respect the diverse beliefs, values and experiences of individuals from different backgrounds.
Improving Health Equity Through Partnerships
Through community partnerships and collaborations with local organizations, leaders, patient advocacy groups and healthcare providers, we are fostering trust among diverse groups, many of which have been historically underrepresented.
Collaborations That Lead to Improved Access and Outcomes
We strive to develop a more inclusive and culturally aware environment for scientific innovation. We are accomplishing this by actively identifying clinical trial sites that serve diverse communities and include diverse research teams.
WHY IT’S IMPORTANT
PROMOTING A FUTURE THAT EMBRACES INCLUSIVITY
Inclusion is one of our core values at Kite and Gilead. We recognize that diverse representation in clinical trials
is essential for ensuring equitable access to healthcare and advancing medical research.
SEARCH KITE AND GILEAD CLINICAL TRIALS
For more information on current or upcoming trials near you, visit our clinical trials search engine.